P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME‐ THE MAYO CLINIC EXPERIENCE
Vaxman, I., Kumar, S., buadi, F., Lacy, M., Dingli, D., Fonder, A., Hobbs, M., Hayman, S., hwa, L. Y., Kouralis, T., Warsame, R., Muchtar, E., Nelson, L., Kapoor, P., Grogan, M., Go, R., Gonsalves, W., Siddiqi, M., Robert, K., Rajkumar, V., Gertz, M., Dispenzieri, A.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article